These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2475586)

  • 1. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H
    Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heredopathia atactica polyneuritiformis (Refsum's disease): 2. Estimation of phytanic acid in foods.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):251-4. PubMed ID: 6157717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum's syndrome). Effect of diet therapy on retinal and cochlear changes].
    Refsum S
    Neurol Neurochir Pol; 1984; 18(1):1-4. PubMed ID: 6203044
    [No Abstract]   [Full Text] [Related]  

  • 6. Is phytanate accumulation pathognomonic for heredopathia atactica polyneuritiformis?
    Aldenhövel HB
    Arch Neurol; 1990 Sep; 47(9):952. PubMed ID: 1697747
    [No Abstract]   [Full Text] [Related]  

  • 7. Heredopathia atactica polyneuritiformis: Refsum's disease.
    Gibberd FB; Billimoria JD; Goldman JM; Clemens ME; Evans R; Whitelaw MN; Retsas S; Sherratt RM
    Acta Neurol Scand; 1985 Jul; 72(1):1-17. PubMed ID: 2413704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phytanic-acid storage disease: Refsum's syndrome. Heredopathia atactica polyneuritiformis].
    Atzpodien W; Thümler R; Kremer GJ
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1480-4. PubMed ID: 71983
    [No Abstract]   [Full Text] [Related]  

  • 10. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):245-50. PubMed ID: 6157716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease).
    Goldman JM; Clemens ME; Gibberd FB; Billimoria JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6475):1109-10. PubMed ID: 2580589
    [No Abstract]   [Full Text] [Related]  

  • 12. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
    Refsum S
    Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Refsum's syndrome (author's transl)].
    Thümler R; Atzpodien W; Kremer GJ; Haferkamp G
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1454-7. PubMed ID: 71982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease:" a biochemically well-defined disease with a specific dietary treatment.
    Refsum S
    Arch Neurol; 1981 Oct; 38(10):605-6. PubMed ID: 6170281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).
    Harari D; Gibberd FB; Dick JP; Sidey MC
    J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):614-7. PubMed ID: 1716665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biochemical follow up of Refsum's disease (author's transl)].
    Barolin GS; Hodkewitsch E; Höfinger E; Scholz H; Bernheimer H; Molzer B
    Fortschr Neurol Psychiatr Grenzgeb; 1979 Feb; 47(2):53-66. PubMed ID: 84779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) in serum using the gas chromatograph GCHF 18.3].
    Pilz D; Kühn HJ
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):556-8. PubMed ID: 6083570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)].
    Feldmann H
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dietary treatment of a patient with Refsum's syndrome (clinical and chemical course observation during a phytol and phytanic acid-poor diet)].
    Thümler R; Atzpodien W; Kremer GJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1084-6. PubMed ID: 77097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.